Publication | Closed Access
Prevalence of asymptomatic vasogenic edema in pretreatment Alzheimer's disease study cohorts from phase 3 trials of semagacestat and solanezumab
76
Citations
6
References
2011
Year
VE seems to be rare at baseline in patients with AD in clinical trials, 2 of 2,762 associated with AD. Additional cohorts should be evaluated to support these findings.
| Year | Citations | |
|---|---|---|
Page 1
Page 1